Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

David Pulford; A. Gates; Simon Bridge; J. H. Robinson; D. Ulaeto

doi:10.1016/j.vaccine.2004.02.034

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

David Pulford, A. Gates, Simon Bridge, J. H. Robinson, D. Ulaeto

Applied Sciences Department

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

39 Downloads (Pure)

Abstract

DNA vaccines might offer an alternative to the live smallpox vaccine in providing protective efficacy in an orthopoxvirus (OPV) lethal respiratory challenge model. BALB/c mice were immunised with DNA vaccines coding for 10 different single vaccinia virus (VACV) membrane proteins. After an intranasal challenge with the VACV IHD strain, three gene candidates B5R, A33R and A27L produced > or =66% survival. The B5R DNA vaccine consistently produced 100% protection and exhibited greatest efficacy after three 50 microg intramuscular doses in this model. Sero-conversion to these vaccines was often inconsistent, implying that antibody itself was not a correlate of protection. The B5R DNA vaccine induced a strong and consistent gamma interferon (IFNgamma) response in BALB/c mice given a single DNA vaccine dose. Strong IFNgamma responses were also measured in pTB5R immunised C57BL6 mice deficient for MHC class I molecules, suggesting that the memory response was mediated by a CD4+ T cell population.

Original language	English
Pages (from-to)	3358-66
Journal	Vaccine
Volume	22
Issue number	25-26
DOIs	https://doi.org/10.1016/j.vaccine.2004.02.034
Publication status	Published - 9 Sept 2004

Keywords

DNA immunisation
B5R
Gamma interferon

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2004.02.034

Pulford et al 2004Final published version, 370 KB

Cite this

@article{1e97039996bc4a8c8f0dee8de4cdef2b,

title = "Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge",

abstract = "DNA vaccines might offer an alternative to the live smallpox vaccine in providing protective efficacy in an orthopoxvirus (OPV) lethal respiratory challenge model. BALB/c mice were immunised with DNA vaccines coding for 10 different single vaccinia virus (VACV) membrane proteins. After an intranasal challenge with the VACV IHD strain, three gene candidates B5R, A33R and A27L produced > or =66% survival. The B5R DNA vaccine consistently produced 100% protection and exhibited greatest efficacy after three 50 microg intramuscular doses in this model. Sero-conversion to these vaccines was often inconsistent, implying that antibody itself was not a correlate of protection. The B5R DNA vaccine induced a strong and consistent gamma interferon (IFNgamma) response in BALB/c mice given a single DNA vaccine dose. Strong IFNgamma responses were also measured in pTB5R immunised C57BL6 mice deficient for MHC class I molecules, suggesting that the memory response was mediated by a CD4+ T cell population.",

keywords = "DNA immunisation, B5R, Gamma interferon",

author = "David Pulford and A. Gates and Simon Bridge and Robinson, {J. H.} and D. Ulaeto",

year = "2004",

month = sep,

day = "9",

doi = "10.1016/j.vaccine.2004.02.034",

language = "English",

volume = "22",

pages = "3358--66",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "25-26",

}

TY - JOUR

T1 - Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

AU - Pulford, David

AU - Gates, A.

AU - Bridge, Simon

AU - Robinson, J. H.

AU - Ulaeto, D.

PY - 2004/9/9

Y1 - 2004/9/9

N2 - DNA vaccines might offer an alternative to the live smallpox vaccine in providing protective efficacy in an orthopoxvirus (OPV) lethal respiratory challenge model. BALB/c mice were immunised with DNA vaccines coding for 10 different single vaccinia virus (VACV) membrane proteins. After an intranasal challenge with the VACV IHD strain, three gene candidates B5R, A33R and A27L produced > or =66% survival. The B5R DNA vaccine consistently produced 100% protection and exhibited greatest efficacy after three 50 microg intramuscular doses in this model. Sero-conversion to these vaccines was often inconsistent, implying that antibody itself was not a correlate of protection. The B5R DNA vaccine induced a strong and consistent gamma interferon (IFNgamma) response in BALB/c mice given a single DNA vaccine dose. Strong IFNgamma responses were also measured in pTB5R immunised C57BL6 mice deficient for MHC class I molecules, suggesting that the memory response was mediated by a CD4+ T cell population.

AB - DNA vaccines might offer an alternative to the live smallpox vaccine in providing protective efficacy in an orthopoxvirus (OPV) lethal respiratory challenge model. BALB/c mice were immunised with DNA vaccines coding for 10 different single vaccinia virus (VACV) membrane proteins. After an intranasal challenge with the VACV IHD strain, three gene candidates B5R, A33R and A27L produced > or =66% survival. The B5R DNA vaccine consistently produced 100% protection and exhibited greatest efficacy after three 50 microg intramuscular doses in this model. Sero-conversion to these vaccines was often inconsistent, implying that antibody itself was not a correlate of protection. The B5R DNA vaccine induced a strong and consistent gamma interferon (IFNgamma) response in BALB/c mice given a single DNA vaccine dose. Strong IFNgamma responses were also measured in pTB5R immunised C57BL6 mice deficient for MHC class I molecules, suggesting that the memory response was mediated by a CD4+ T cell population.

KW - DNA immunisation

KW - B5R

KW - Gamma interferon

U2 - 10.1016/j.vaccine.2004.02.034

DO - 10.1016/j.vaccine.2004.02.034

M3 - Article

SN - 0264-410X

VL - 22

SP - 3358

EP - 3366

JO - Vaccine

JF - Vaccine

IS - 25-26

ER -

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this